Physician profile
Erin E Gray
NPI 1073789798
$118,305.84
in general payments reported to CMS, 2019-2025
32 companies · $19K in 2025
The $19K reported for 2025 was more than what 99% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $497 · 2022: $2,166 · 2023: $57K · 2024: $40K · 2025: $19K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $99K · Travel and Lodging: $8,087 · Food and Beverage: $7,463 · Consulting Fee: $1,020 · Education: $373.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $98,700.00 |
| Travel and Lodging | $8,086.72 |
| Food and Beverage | $7,463.22 |
| Consulting Fee | $1,020.00 |
| Education | $372.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $109,880.98 | 2021-2025 | Olumiant, Taltz, Ebglyss |
| Incyte Corporation | $1,261.71 | 2022-2024 | Opzelura |
| Abbvie INC. | $1,100.23 | 2021-2025 | |
| Janssen Biotech, INC. | $981.50 | 2021-2025 | Tremfya |
| Pfizer INC. | $812.52 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $757.37 | 2021-2025 | Sotyktu |
| Novartis Pharmaceuticals Corporation | $513.24 | 2022-2025 | |
| Amgen INC. | $510.22 | 2021-2025 | Otezla, Otezla |
| Ucb, INC. | $483.68 | 2021-2025 | Bimzelx, Cimzia |
| Sun Pharmaceutical Industries INC. | $412.44 | 2022-2025 | Winlevi, Blu-U, Odomzo |
| Genzyme Corporation | $292.94 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $229.82 | 2022-2025 | Dupixent |
| Leo Pharma INC. | $191.79 | 2022-2025 | Adbry, Anzupgo |
| Arcutis Biotherapeutics, INC. | $160.43 | 2023-2025 | Zoryve |
| Dermavant Sciences, INC. | $148.38 | 2022-2024 | Vtama |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $81.29 | 2025 | Vtama |
| Boehringer Ingelheim Pharmaceuticals, INC. | $60.08 | 2022-2024 | Cyltezo |
| Botanix Sb INC | $57.15 | 2025 | Sofdra |
| Glaxosmithkline, LLC. | $38.76 | 2021-2022 | |
| Alexion Pharmaceuticals, INC. | $38.24 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $37.07 | 2022 | |
| Verrica Pharmaceuticals INC. | $29.55 | 2023 | Ycanth |
| Horizon Therapeutics Plc | $28.75 | 2022 | |
| Fresenius Kabi USA, LLC | $25.33 | 2023 | Idacio |
| Abbott Laboratories | $24.15 | 2025 | Xience Skypoint |
| Journey Medical Corporation | $24.12 | 2024 | |
| Merz North America, INC. | $23.84 | 2023 | Xeomin |
| Mallinckrodt Hospital Products INC. | $23.60 | 2022 | |
| Daiichi Sankyo INC. | $22.97 | 2022 | |
| Aurinia Pharma U.S., INC. | $20.73 | 2022 | |
| Ani Pharmaceuticals, INC. | $18.49 | 2022 | |
| Biofrontera INC. | $14.47 | 2023 | Xepi, Bf-Rhodoled, Ameluz |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Gray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.